Literature DB >> 25380707

Laparoscopic anti-reflux revision surgery after transoral incisionless fundoplication is safe and effective.

Reginald C W Bell1, Ashwin A Kurian, Katherine D Freeman.   

Abstract

BACKGROUND: Transoral incisionless fundoplication (TIF) treats gastroesophageal reflux disease (GERD) by creating a full-thickness esophagogastric plication using transmural fasteners. If unsuccessful, revision laparoscopic anti-reflux surgery (rLARS) may be performed. This study evaluated operative findings and clinical outcomes of rLARS in 28 patients with prior primary TIF.
METHODS: Intraoperative findings, complications, and symptomatic outcomes with GERD health-related quality of life (GERD-HRQL) were evaluated prospectively in patients having rLARS after TIF. Results are median with interquartile range (IQR).
RESULTS: Between 03/2009 and 08/2013, 28 patients underwent rLARS at 14 (13-50) months post-TIF for recurrent symptoms after initial improvement. Pre-rLARS endoscopies found hiatal hernia (9) and wrap disruption (12). All revisions were completed laparoscopically in 88 (70-90) min. Eight patients underwent partial fundoplication, the rest Nissen. No intraoperative or postoperative complications occurred. Operative findings included: No axial hernia in 65%; Dense adhesions in 14%; Fasteners incorporating the lateral crus in 95%; Traction diverticuli from esophagus to crura in 21%. Residual plication was noted anteriorly in 75%, posteriorly in 0%. Operative approaches: (1) Areas where the TIF fundoplication remained were left intact. This necessitated rolling the fundoplication over the fused area to prevent an endoscopic appearance of 'fold'. (2) Fasteners were cut and left to migrate into the lumen, rather than being pulled out. (3) In 8 patients with fusion of the lateral crus to TIF fundoplication and no axial hernia, revision fundoplication was performed without mediastinal mobilization but with posterior hernia repair. One patient required subsequent surgery for small paraesophageal hernia, one for refractory gas-bloat after rLARS. Dysphagia in 2 patients resolved with dilation. GERD-HRQL improved from a median of 20 (8-27) pre-TIF and 10 (1-20) pre-rLARS to 3 (0-4) at 28 months (12-40) post-rLARS (p = 0.020 for pre-rLARS to post-rLARS).
CONCLUSION: rLARS after TIF can be performed safely with excellent clinical outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 25380707     DOI: 10.1007/s00464-014-3897-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  17 in total

1.  Patterns of success and failure with laparoscopic Toupet fundoplication.

Authors:  R C Bell; P Hanna; M R Mills; D Bowrey
Journal:  Surg Endosc       Date:  1999-12       Impact factor: 4.584

2.  Transoral incisionless fundoplication 2.0 procedure using EsophyX™ for gastroesophageal reflux disease.

Authors:  Toshitaka Hoppo; Arul Immanuel; Matthew Schuchert; Zdenek Dubrava; Andrew Smith; Peter Nottle; David I Watson; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2010-09-28       Impact factor: 3.452

3.  Revisional laparoscopic antireflux surgery after unsuccessful endoscopic fundoplication.

Authors:  Bart P L Witteman; Boudewijn F Kessing; Gitte Snijders; Ger H Koek; José M Conchillo; Nicole D Bouvy
Journal:  Surg Endosc       Date:  2013-01-05       Impact factor: 4.584

4.  A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.

Authors:  Reginald C W Bell; Peter G Mavrelis; William E Barnes; David Dargis; Bart J Carter; Kevin M Hoddinott; Robert W Sewell; Karim S Trad; Brian DaCosta Gill; Glenn M Ihde
Journal:  J Am Coll Surg       Date:  2012-08-29       Impact factor: 6.113

5.  A prospective, randomized trial of laparoscopic polytetrafluoroethylene (PTFE) patch repair vs simple cruroplasty for large hiatal hernia.

Authors:  Constantine T Frantzides; Atul K Madan; Mark A Carlson; George P Stavropoulos
Journal:  Arch Surg       Date:  2002-06

Review 6.  Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature.

Authors:  Mark R Wendling; W Scott Melvin; Kyle A Perry
Journal:  Surg Endosc       Date:  2013-05-04       Impact factor: 4.584

7.  Transoral incisionless fundoplication does not significantly increase morbidity of subsequent laparoscopic Nissen fundoplication.

Authors:  Kyle A Perry; John G Linn; Jeffery L Eakin; Raymond P Onders; Vic Velanovich; W Scott Melvin
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2013-04-11       Impact factor: 1.878

8.  Allograft dermal matrix hiatoplasty during laparoscopic primary fundoplication, paraesophageal hernia repair, and reoperation for failed hiatal hernia repair.

Authors:  Reginald C W Bell; Jacqueline Fearon; Katherine D Freeman
Journal:  Surg Endosc       Date:  2013-01-09       Impact factor: 4.584

9.  Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations.

Authors:  Reginald C W Bell; Guy-Bernard Cadière
Journal:  Surg Endosc       Date:  2010-12-24       Impact factor: 4.584

10.  Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease.

Authors:  V Velanovich
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

View more
  5 in total

Review 1.  Endoscopic Options for Gastroesophageal Reflux: Where Are We Now and What Does the Future Hold?

Authors:  George Triadafilopoulos
Journal:  Curr Gastroenterol Rep       Date:  2016-09

2.  Update on Endoscopic Approaches for the Management of Gastroesophageal Reflux Disease.

Authors:  Zaheer Nabi; D Nageshwar Reddy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-07

3.  The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.

Authors:  Karim S Trad; William E Barnes; Elizabeth R Prevou; Gilbert Simoni; Jennifer A Steffen; Ahmad B Shughoury; Mamoon Raza; Jeffrey A Heise; Mark A Fox; Peter G Mavrelis
Journal:  Surg Innov       Date:  2018-02-06       Impact factor: 2.058

4.  Transoral incisionless fundoplication demonstrates durability at up to 9 years.

Authors:  Reginald C W Bell; Katherine Freeman; Rachel Heidrick; Shahin Ayazi
Journal:  Therap Adv Gastroenterol       Date:  2021-04-16       Impact factor: 4.409

5.  Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.

Authors:  Karim S Trad; Mark A Fox; Gilbert Simoni; Ahmad B Shughoury; Peter G Mavrelis; Mamoon Raza; Jeffrey A Heise; William E Barnes
Journal:  Surg Endosc       Date:  2016-09-21       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.